Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: A randomized sequence, open-label, two-way crossover study
Authors:
- 31 October 2009
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 31 (10) , 2242-2248
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Orally Disintegrating Systems: Innovations in Formulation and TechnologyRecent Advances in Drug Delivery and Formulation, 2008
- Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in JapaneseEuropean Journal of Clinical Pharmacology, 2006
- The CYP2C19 Enzyme PolymorphismPharmacology, 2000
- Population‐based studies of the epidemiology of benign prostatic hyperplasiaBritish Journal of Urology, 1998
- Finasteride in the treatment of men with androgenetic alopeciaJournal of the American Academy of Dermatology, 1998
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- Clinical Pharmacokinetics and Pharmacodynamics of FinasterideClinical Pharmacokinetics, 1996
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987